| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 844 | 2016 |
| Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. PRINTO, PRCSG. New England Journal of Medicine 367 (25), 2396-406, 2012 | 792 | 2012 |
| Recommendations for the management of hemophagocytic lymphohistiocytosis in adults P La Rosée, AC Horne, M Hines, T von Bahr Greenwood, R Machowicz, ... Blood, The Journal of the American Society of Hematology 133 (23), 2465-2477, 2019 | 780 | 2019 |
| Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies AK Akobeng, AV Ramanan, I Buchan, RF Heller Archives of disease in childhood 91 (1), 39-43, 2006 | 677 | 2006 |
| Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 … VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ... The lancet Respiratory medicine 9 (12), 1407-1418, 2021 | 664 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 639* | 2021 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis AV Ramanan, AD Dick, AP Jones, A McKay, PR Williamson, ... New England Journal of Medicine 376 (17), 1637-1646, 2017 | 401 | 2017 |
| A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process R Harwood, B Allin, CE Jones, E Whittaker, P Ramnarayan, AV Ramanan, ... The Lancet Child & Adolescent Health 5 (2), 133-141, 2021 | 364 | 2021 |
| The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic … J Bleesing, A Prada, DM Siegel, J Villanueva, J Olson, NT Ilowite, ... Arthritis & Rheumatism 56 (3), 965-971, 2007 | 364 | 2007 |
| Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Annals of the rheumatic diseases 74 (6), 1110-1117, 2015 | 305 | 2015 |
| Use of methotrexate in juvenile idiopathic arthritis AV Ramanan, P Whitworth, EM Baildam Archives of disease in childhood 88 (3), 197-200, 2003 | 274* | 2003 |
| Coronavirus disease 2019 (COVID-19) in children-what we know so far and what we do not S Balasubramanian, NM Rao, A Goenka, M Roderick, AV Ramanan Indian pediatrics 57, 435-442, 2020 | 268 | 2020 |
| Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis H Gunawardena, LR Wedderburn, H Chinoy, ZE Betteridge, J North, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 263 | 2009 |
| Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment SJ Carter, RS Tattersall, AV Ramanan Rheumatology 58 (1), 5-17, 2019 | 247 | 2019 |
| Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. AV Ramanan, R Schneider The Journal of rheumatology 30 (2), 401-403, 2003 | 231 | 2003 |
| Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr, AP Brézin, SP Chee, ... Ophthalmology 125 (5), 757-773, 2018 | 228 | 2018 |
| 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis … R Aggarwal, LG Rider, N Ruperto, N Bayat, B Erman, BM Feldman, ... Arthritis & Rheumatology 69 (5), 898-910, 2017 | 224 | 2017 |
| Chronic recurrent multifocal osteomyelitis (CRMO)–advancing the diagnosis MR Roderick, R Shah, V Rogers, A Finn, AV Ramanan Pediatric Rheumatology 14, 1-5, 2016 | 221 | 2016 |
| Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label … AS Soin, K Kumar, NS Choudhary, P Sharma, Y Mehta, S Kataria, D Govil, ... The Lancet Respiratory Medicine 9 (5), 511-521, 2021 | 219 | 2021 |
